Portage Biotech Hosting Key Opinion Leader Event on Targetin

Targeting Adenosine for Cancer:Challenging Past Assumptions with Next-Generation Small Molecule Inhibitors Thursday, March 9th @ 10:30 am ET WESTPORT, Conn., Feb. 27, 2023 -- Portage Biotech Inc.... | February 27, 2023

Related Keywords

California , United States , Texas , San Francisco , Westport , Lawrence Fong , Gwendolyn Schanker , Sumit Subudhi , Chuck Padala , University Of California , Department Of Genitourinary Medical Oncology , Linkedin , University Of Texas Md Anderson Cancer Center , Cancer Immunology Program , Md Anderson Cancer Center , Portage Biotech Inc , Nasdaq , Company Annual Report On Form , Division Of Hematology Oncology , Parker Institute For Cancer Immunotherapy , Cancer Immunotherapy Program , Department Of Medicine , Helen Diller Family Comprehensive Cancer Center , Globenewswire Inc , Targeting Adenosine , Past Assumptions , Next Generation Small Molecule , Cancer Center , Efim Guzik Distinguished Professor , Cancer Biology , Diller Family Comprehensive Cancer , Associate Professor , Genitourinary Medical Oncology , Portage Biotech , Annual Report , Portage Biotech Inc Stock Exchange , News , Information , Press Release , Targeting , Adenosine , Or , Mast , Assumptions , Ith , Mall , Olecule , Inhibitors , Arch , M , 023 , Portage , Iotech Prtg Vgg7185a1286 ,